<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00634803</url>
  </required_header>
  <id_info>
    <org_study_id>HIC0608001776</org_study_id>
    <nct_id>NCT00634803</nct_id>
  </id_info>
  <brief_title>Clinical Trial of Integrated Treatment for Pain and Opioid Dependence</brief_title>
  <acronym>POD</acronym>
  <official_title>Clinical Trial of Integrated Treatment for Pain and Opioid Dependence</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yale University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yale University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed to develop an effective psychotherapy for chronic pain and opioid
      dependence.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study aims to develop a novel manualized intervention using tailored
      cognitive-behavioral treatment (CBT) and buprenorphine medication to effectively treat the
      co-occurring disorders of non-malignant pain and opioid dependence (POD).

      Specific Aims:

        1. To conduct a pre-pilot phase with 16 patients with POD receiving buprenorphine
           maintenance treatment (BMT). In the pre-pilot phase, we will also explore the effects of
           different daily buprenorphine dosages on pain and opiate use.

        2. To conduct a pilot randomized, clinical trial to obtain data regarding the feasibility,
           acceptability and efficacy (compared to Physician Management(PM) only) of manual-guided
           CBT or Educational Counseling (EC) for patients with POD treated with BMT (N=75).
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2009</start_date>
  <completion_date type="Anticipated">August 2015</completion_date>
  <primary_completion_date type="Anticipated">May 2015</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain reduction</measure>
    <time_frame>16 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Reduced illicit opioid use</measure>
    <time_frame>16 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Development of a treatment manual</measure>
    <time_frame>16 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Development and modification of initial therapy training and process rating measures</measure>
    <time_frame>16 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">91</enrollment>
  <condition>Opiate Dependence</condition>
  <condition>Chronic Pain</condition>
  <arm_group>
    <arm_group_label>CBT for POD</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Integrated cognitive behavioral therapy for chronic pain and opioid dependence</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Educational Counseling for POD</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Educational Counseling is a didactic, lecture-discussion format to supplement the information and advice provided by physicians in physician management (PM)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Physician Management</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>PM is a relatively brief intervention that approximates the medically focused advice and brief counseling about medical issues that is typically provided by physicians to patients with chronic pain or other chronic medical conditions, such as diabetes or asthma.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>CBT</intervention_name>
    <description>Cognitive behavioral therapy</description>
    <arm_group_label>CBT for POD</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Buprenorphine</intervention_name>
    <description>buprenorphine/naloxone</description>
    <arm_group_label>CBT for POD</arm_group_label>
    <arm_group_label>Educational Counseling for POD</arm_group_label>
    <arm_group_label>Physician Management</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Educational Counseling</intervention_name>
    <description>Didactic, lecture-discussion format to supplement information and advice provided by physicians</description>
    <arm_group_label>Educational Counseling for POD</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Physician Management</intervention_name>
    <description>Brief physician counseling</description>
    <arm_group_label>Physician Management</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years of age or older

          -  prescription opioid addiction criteria

          -  moderate to severe chronic pain

          -  seeking or interested in buprenorphine maintenance

          -  understand English

        Exclusion Criteria:

          -  methadone maintenance at a dose greater than 40 mg daily

          -  current suicide or homicide risk

          -  life-threatening or unstable medical problem

          -  pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard S Schottenfeld, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Yale University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Declan T Barry, PhD</last_name>
    <phone>203-285-2708</phone>
    <email>declan.barry@yale.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Richard S Schottenfeld, MD</last_name>
    <phone>203-974-7349</phone>
    <email>richard.schottenfeld@yale.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Methadone Research Unit</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06519</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christopher Cutter, PhD</last_name>
      <email>christopher.cutter@yale.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 2, 2008</study_first_submitted>
  <study_first_submitted_qc>March 6, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 13, 2008</study_first_posted>
  <last_update_submitted>September 29, 2014</last_update_submitted>
  <last_update_submitted_qc>September 29, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 30, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chronic Pain</mesh_term>
    <mesh_term>Opioid-Related Disorders</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Analgesics, Opioid</mesh_term>
    <mesh_term>Buprenorphine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

